References
Apr 1, 1993·The American Review of Respiratory Disease·D A Mitchison
Sep 7, 2001·Annual Review of Microbiology·L G Wayne, C D Sohaskey
Oct 9, 2002·Microbiology·Natalie J GartonMichael R Barer
Nov 1, 1956·The Journal of Experimental Medicine·R M MCCUNE, R TOMPSETT
Sep 27, 2003·The Journal of Infectious Diseases·Troels LillebaekAse B Andersen
Nov 1, 2003·The Journal of Infectious Diseases·Peter SeilerPeter Aichele
Dec 13, 2003·Tuberculosis·James E Gomez, John D McKinney
Jun 9, 2004·Microbiology·Margarita ShleevaArseny S Kaprelyants
Jun 23, 2004·Tuberculosis·Tobias HampshirePhilip D Butcher
Mar 29, 2005·Antimicrobial Agents and Chemotherapy·C WiuffB R Levin
Jun 6, 2006·The Journal of Antimicrobial Chemotherapy·Ping ChenCarol A Nacy
Jan 12, 2007·Current Opinion in Microbiology·Neeraj Dhar, John D McKinney
Jan 24, 2007·Antimicrobial Agents and Chemotherapy·Boris V NikonenkoCarol A Nacy
Mar 29, 2007·PLoS Medicine·Lynn E ConnollyLalita Ramakrishnan
Oct 10, 2008·Tuberculosis·P R Donald, A H Diacon
Apr 1, 2009·Microbiology·Aleksey M AnuchinArseny S Kaprelyants
Apr 25, 2009·Cellular Microbiology·Tige R RustadDavid R Sherman
Jun 30, 2009·PloS One·Chirajyoti DebPappachan E Kolattukudy
Oct 31, 2009·American Journal of Respiratory and Critical Care Medicine·Galina V MukamolovaMichael R Barer
Jan 26, 2011·Tuberculosis·Margarita O ShleevaArseny S Kaprelyants
Mar 8, 2011·Cell·Kristin N AdamsLalita Ramakrishnan
Jun 21, 2011·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·A H DiaconP R Donald
Jul 7, 2011·PLoS Pathogens·Jaiyanth DanielPappachan E Kolattukudy
Jan 27, 2012·PloS One·Robert S WallisPaul F Miller
Jul 26, 2012·Future Microbiology·Katherine A SackstederCarol A Nacy
Jul 26, 2012·PloS One·Christer LarssonWilliam R Bishai
Jan 9, 2013·Antimicrobial Agents and Chemotherapy·Brian W KwanThomas K Wood
Sep 28, 2013·The Journal of Antimicrobial Chemotherapy·Jasvir DhillonDenis A Mitchison
Jan 8, 2014·Expert Review of Anti-infective Therapy·Andreas H Diacon, Peter R Donald
Mar 20, 2014·Nature Methods·Martin Krzywinski, Naomi Altman
Sep 10, 2014·The New England Journal of Medicine·Stephen H GillespieUNKNOWN REMoxTB Consortium
Oct 23, 2014·The New England Journal of Medicine·Corinne S MerleUNKNOWN OFLOTUB/Gatifloxacin for Tuberculosis Project
Oct 23, 2014·The New England Journal of Medicine·Amina JindaniUNKNOWN RIFAQUIN Trial Team
Jan 30, 2015·The Journal of Antimicrobial Chemotherapy·Norbert HeinrichUNKNOWN Pan African Consortium for the Evaluation of Antituberculosis Antibiotics PanACEA
Mar 18, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Derek J SloanGeraint R Davies
Citations
Feb 6, 2016·BMC Medicine·Patrick P J PhillipsStephen H Gillespie
Mar 8, 2016·Expert Opinion on Drug Metabolism & Toxicology·Marlanka A ZuurJan-Willem C Alffenaar
Apr 1, 2016·Expert Review of Respiratory Medicine·Neesha RockwoodRobert J Wilkinson
May 3, 2018·The Journal of Infectious Diseases·Robin J SvenssonUlrika S H Simonsson
Jul 31, 2019·Antimicrobial Agents and Chemotherapy·Robin J SvenssonUlrika S H Simonsson
Aug 9, 2018·Frontiers in Immunology·Juliane RadloffBarbara Kalsdorf
Jan 31, 2018·Frontiers in Microbiology·Srinivasan VijayNguyen T T Thuong
Jul 7, 2021·Antimicrobial Agents and Chemotherapy·Oluwaseun EgbelowoVéronique Dartois
Oct 5, 2021·Lipids in Health and Disease·Daniel MekonnenAbraham Aseffa